⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL57409 | 1.00 | — | — | |
| SCHEMBL88559 | 1.00 | — | — | |
| SCHEMBL22069894 | 0.98 | PIK3CD (0.32) | — | |
| Lithium SCHEMBL38658000 | 0.98 | PIK3CD (0.32) | — | |
| SCHEMBL9374856 | 0.98 | PIK3CD (0.32) | — | |
| SCHEMBL16045961 | 0.83 | — | — | |
| SCHEMBL21378367 | 0.83 | — | — | |
| SCHEMBL22158785 | 0.83 | — | — | |
| SCHEMBL22201554 | 0.83 | — | — | |
| SCHEMBL16055022 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 339 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119798181-A | (R) -4-isopropyl-3- ((R) -2-methyl-5-hexenoyl) oxazolidin-2-one and application thereof in synthesis of inchworm sex pheromone component of Western iron yew | 山东省农业科学院 | 2025-04-11 | — | — | CN | claimed |
| CN-112264101-B | Preparation method and application of metal organic framework catalyst with torsion structure | 大连理工大学 | 2021-12-31 | — | — | CN | claimed |
| CN-110041206-B | Preparation method of cinacalcet impurity | 梯尔希（南京）药物研发有限公司 | 2021-10-19 | — | — | CN | claimed |
| CN-112264101-A | Preparation method and application of metal organic framework catalyst with torsion structure | 大连理工大学 | 2021-01-26 | — | — | CN | claimed |
| CN-102477016-B | Synthesis and application of intermediate of tapentadol | INST MATERIA MEDICA CAMS | 2014-12-17 | — | — | CN | claimed |
| CN-102477016-A | Synthesis and application of intermediate of tapentadol | INST MATERIA MEDICA CAMS | 2012-05-30 | — | — | CN | claimed |
| EP-0594608-B1 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS | RES CORP TECHNOLOGIES INC (US) | 1997-10-15 | — | — | EP | claimed |
| EP-0594608-A1 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS. | RES CORP TECHNOLOGIES INC (US) | 1994-05-04 | — | — | EP | claimed |
| EP-0594608-A4 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS. | RES CORP TECHNOLOGIES INC (US) | 1993-03-15 | — | — | EP | claimed |
| WO-1991014672-A1 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-10-03 | — | — | WO | claimed |
| US-20260091081-A1 | A FORMULATION OF A CONJUGATE OF A TUBULYSIN ANALOG TO A CELL-BINDING MOLECULE | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-04-02 | — | — | US | disclosed |
| EP-4714446-A2 | PHARMACEUTICAL COMPOUNDS | Nxera Pharma UK Limited (GB) | 2026-03-25 | — | — | EP | disclosed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | disclosed |
| EP-4630410-A1 | POLQ INHIBITORS | Astrazeneca AB (SE) | 2025-10-15 | — | — | EP | disclosed |
| US-12414954-B2 | POLQ inhibitors | ASTRAZENECA AB (SE) | 2025-09-16 | — | — | US | disclosed |
| EP-0621270-A1 | COLLAGENASE INHIBITOR | SANKYO COMPANY LIMITED (JP) | 1994-10-26 | — | — | EP | disclosed |
| WO-1994007849-A1 | PROCESS FOR THE STEREOSELECTIVE SYNTHESIS OF 3-SUBSTITUTED 2-THIOMETHYL PROPIONIC ACIDS | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-04-14 | — | — | WO | disclosed |
| US-5242903-A | Enzyme inhibitors | BAYER AKTIENGESELLSCHAFT (DE) | 1993-09-07 | — | — | US | disclosed |
| US-5095006-A | Enzyme inhibitors | BAYER AKTIENGESELLSCHAFT (DE) | 1992-03-10 | — | — | US | disclosed |
| EP-0412350-A2 | Renininhibitors, procedure for their preparation and use as medicaments | BAYER AG (DE) | 1991-02-13 | — | — | EP | disclosed |